KANHA is excited to announce that we are partnering with Juva Life in a groundbreaking research study – the JuLi Registry.
Juva Life is a life sciences portfolio company with operations in pharmaceutical research and development as well as cannabis production and distribution.
We have been selected to participate with one or more of our best-in-class products.
People with the following symptoms may be eligible for this study:
- Chronic pain
- Anxiety
- Neuropathy
- Appetite issues
- Nausea
- Sleep issues
- Menopausal symptoms
The goal of the JuLi Registry is to correlate symptoms with hemp-derived CBD and cannabis-based management approaches and look at how these products benefit patients with disease-related symptoms and other health conditions. Eventually, results from this study may benefit people from all over the world seeking hemp- and cannabis-based health solutions.
Participants will choose from a curated list of products and be provided dosing recommendations. Participants may obtain products from their preferred dispensary or delivery service. In the case of hemp-derived CBD, the product can be shipped directly to the participant.
Participants will complete confidential surveys at various time points and use a mobile journaling app to track daily results. Participants are asked to participate for three months. Modest compensation in the form of gift cards from over 200 retailers is provided for completing the enrollment and follow-up surveys and for using the journaling app.
We invite you to join us and Juva in advancing the understanding of cannabis and hemp-based products for improving wellness!
To see if you may qualify and to learn more about the study, please visit this link
